Cancer52 have joined 53 other cancer charities as One Cancer Voice to agree a Consensus Statement for submission as part of the...

In December 2020, Cancer52 submitted a consultation response from Cancer52 to the NICE Methods Review. The response was supported by 23...

On 1 March 2018, Cancer52 responded to the NICE Centre for Health Technology Evaluation's Consultation on updated Technology Appraisal...

In November 2017 Cancer52 responded to the NICE Centre for Health Technology Evaluation consultation entitled “Increasing capacity within...

Cancer52 submitted written evidence to the APPGC Cancer Strategy inquiry, as the Cancer Strategy Achieving World-Class Cancer Outcomes: A...

Cancer52 has responded on the above consultation (February 2017) and full response can be found here. The topic was discussed at the...

Cancer52 has responded to the above consultation (January 2017). The full response can be found here. In summary Cancer52 disagreed with...

Cancer52 has responded to the above consultation (January 2017). The full response can be found here. The consultation covers four areas...

On 15th June 2015, Cancer52 responded to the proposed changes to the Standard Operating Procedures: Cancer Drugs Fund 2015-16. In...

On 23rd April 2015, Cancer52 responded to the NHS public consultation on Investing in Specialised Services. In summary Cancer52 believes...